THE IMPACT OF IMMUNOHISTOCHEMICAL MARKER INDICATORS ON TREATMENT OUTCOMES IN ENDOMETRIAL ATYPICAL HYPERPLASIA. Wor.Bul.Pub.Helt. 2025, 52, 46-50.